TLR4 and breast carcinoma: Previously, Lapteva et al. reported that the anti-tumor effect of Ad-based intratumoral vaccines was abrogated in TLR4 deficient (TLR4−/−) mice harboring mouse breast cancer cells, supporting the critical role of TLR4 signaling in the induction of anti-tumor immunity induced by Ad vectors [30].